Demant A/S Stock Rises Amid Global Volatility, Backed by Bernstein’s ‘Outperform’ Rating
Demant A/S’s stock price has seen a moderate increase following a Bernstein upgrade to ‘outperform’ due to its strong growth prospects and established position in the health care industry.
2 minutes to read